Banner

Macular Degeneration Treatment Global Market Report 2023 – By Stage of Disease (Early Stage AMD Intermediate AMD Late Stage AMD), By End User (Ambulatory Surgical Centers Ophthalmic Clinics Hospitals), By Route of Administration (Oral Injectable Other Route of Administration), By Types (Wet Macular Degeneration, Dry Macular Degeneration) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : h1471 | Delivery Time: 2-3 business days | Format :


Macula refers to the central portion of the retina, a light-sensitive layer of tissue at the back of the eye. The macula is responsible for central vision. Degeneration of the macula, which affects the central part of the retina (the macula) and results in distortion or loss of central vision, occurs most commonly after the age of 60 and is referred to as age-related macular generation (AMD). The macular degeneration treatment is used to treat macular degeneration eye disease and slow the disease and prevent severe loss of vision.

The main disease stages in the macular degeneration treatment market are early-stage AMD, intermediate AMD, and late-stage AMD. In early-stage AMD, the macula changes, with medium-sized drusen deposits and no pigment changes, but this does not impact vision. Intermediate AMD is when vision may get blurry or wavy with large drusen or pigment changes. In late-stage AMD, the central vision fails completely, causing vision loss. The different types of macular degeneration treatments include wet macular degeneration and dry macular degeneration. The different routes of administration of macular degeneration treatment include oral, injectable, and others used by different end-users such as ambulatory surgical centers, ophthalmic clinics, and hospitals.

The macular degeneration treatment research report is one of a series of new reports from The Business Research Company that provides macular degeneration treatment statistics, including macular degeneration treatment industry global market size, regional shares, competitors with macular degeneration treatment shares, detailed macular degeneration treatment segments, market trends and opportunities, and any further data you may need to thrive in the macular degeneration treatment industry. This macular degeneration treatment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The global macular degeneration treatment market size grew from $8.44 billion in 2022 to $9.43 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The macular degeneration treatment market size is expected to grow to $14.3 billion in 2027 at a CAGR of 11.0%.

The increasing burden of retinal disorders is expected to propel the growth of the macular degeneration treatment market. Retinal disorders affect the vital tissue and affect the way individuals process visual information, leading to distorted or absent vision. According to a study done in Tanzania in 2020 about the prevalence of retinal diseases and associated risk factors, out of 1,007 people, the prevalence of vitreoretinal disorders was 22.8% (230/1,007). The study was conducted by OSLI Retina, which focuses solely on retinal diseases, surgery, and pharmacotherapy. The leading retinal diseases were age-related hypertensive macular scars (2.7%), retinopathy (4.5%), and degeneration (7.0%). According to the American Academy of Opthalmology, in 2050, an estimated 7.32 million people in the United States will have primary open-angle glaucoma, with the highest numbers among populations aged 70 to 79 years (32%), women (50%), and Hispanics (50%). The largest demographic group is Hispanic men. Therefore, the increasing burden of retinal disorders is driving the growth of the macular degeneration treatment market.

The development of advanced therapies is a key trend gaining popularity in the macular degeneration treatment market. Advanced therapy, including gene therapy, for the treatment of disease has seen development in recent years, particularly in the world of inherited retinal disease. For instance, in October 2021, Genentech, a US-based biotechnology company, announced that FDA has approved Susvimo, a new treatment for wet age-related macular degeneration. Susvimo is the first wet AMD treatment to offer an alternative to the standard-of-care eye injections required as frequently as once per month in the last 15 years. Susvimo will help people with wet AMD retain their vision with as few as two treatments per year by continually injecting medication into the eye via a refillable implant.

In September 2021, Novartis, a Swiss-based pharmaceutical company, acquired Arctos Medical for an undisclosed amount. The acquisition is expected to allow Novartis to find treatments for patients with vision loss and leverage the potential of optogenetics as the basis of successful therapeutics. Arctos Medical is a Switzerland-based developer of smart medical devices and gene therapy approaches for ophthalmological diseases for treating blindness.

Major players in the macular degeneration treatment market are Novartis AG, Bausch Health Companies Inc., Regenxbio Inc., F Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., GlaxoSmithKline plc, Bayer AG, Neurotech Pharmaceuticals Inc., Ophthotech Corporation, StemCells Inc., Pfizer Inc., Santen Pharmaceuticals, Alimera Sciences Inc., Aerie Pharmaceutical Inc., Panoptica, Allergan Inc., Valeant Pharmaceuticals, and Rxi Pharmaceuticals Inc.

In 2022, North America will be the largest region in the macular degeneration treatment market. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the Macular Degeneration Treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The macular degeneration treatment market includes revenues earned by entities by anti-angiogenic drugs, photodynamic therapy, laser therapy and low vision aids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global macular degeneration treatment market is segmented -

1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD

2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals

3) By Route of Administration: Oral, Injectable, Other Route of Administration

4) By Types: Wet Macular Degeneration, Dry Macular Degeneration

    Table Of Contents

    1. Executive Summary

    2. Macular Degeneration Treatment Market Characteristics

    3. Macular Degeneration Treatment Market Trends And Strategies

    4. Macular Degeneration Treatment Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Macular Degeneration Treatment Market

    4.2 Ukraine-Russia War Impact On Macular Degeneration Treatment Market

    4.3 Impact Of High Inflation On Macular Degeneration Treatment Market

    5. Macular Degeneration Treatment Market Size And Growth

    5.1. Global Macular Degeneration Treatment Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Macular Degeneration Treatment Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Macular Degeneration Treatment Market Segmentation

    6.1. Global Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Wet Macular Degeneration

    Dry Macular Degeneration

    6.2. Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Early-Stage AMD

    Intermediate AMD

    Late-Stage AMD

    6.3. Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Oral

    Injectable

    Other Route of Administration

    6.4. Global Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Ambulatory Surgical Centers

    Ophthalmic Clinics

    Hospitals

    7. Macular Degeneration Treatment Market Regional And Country Analysis

    7.1. Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Macular Degeneration Treatment Market

    8.1. Asia-Pacific Macular Degeneration Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Macular Degeneration Treatment Market

    9.1. China Macular Degeneration Treatment Market Overview

    9.2. China Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Macular Degeneration Treatment Market

    10.1. India Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Macular Degeneration Treatment Market

    11.1. Japan Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Macular Degeneration Treatment Market

    12.1. Australia Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Macular Degeneration Treatment Market

    13.1. Indonesia Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Macular Degeneration Treatment Market

    14.1. South Korea Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Macular Degeneration Treatment Market

    15.1. Western Europe Macular Degeneration Treatment Market Overview

    15.2. Western Europe Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Macular Degeneration Treatment Market

    16.1. UK Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Macular Degeneration Treatment Market

    17.1. Germany Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Macular Degeneration Treatment Market

    18.4. France Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Macular Degeneration Treatment Market

    19.1. Eastern Europe Macular Degeneration Treatment Market Overview

    19.2. Eastern Europe Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Macular Degeneration Treatment Market

    20.1. Russia Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Macular Degeneration Treatment Market

    21.1. North America Macular Degeneration Treatment Market Overview

    21.2. North America Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Macular Degeneration Treatment Market

    22.1. USA Macular Degeneration Treatment Market Overview

    22.2. USA Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Macular Degeneration Treatment Market

    23.1. South America Macular Degeneration Treatment Market Overview

    23.2. South America Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Macular Degeneration Treatment Market

    24.1. Brazil Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Macular Degeneration Treatment Market

    25.1. Middle East Macular Degeneration Treatment Market Overview

    25.2. Middle East Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Macular Degeneration Treatment Market

    26.1. Africa Macular Degeneration Treatment Market Overview

    26.2. Africa Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Macular Degeneration Treatment Market Competitive Landscape And Company Profiles

    27.1. Macular Degeneration Treatment Market Competitive Landscape

    27.2. Macular Degeneration Treatment Market Company Profiles

    27.2.1. Novartis AG

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Bausch Health Companies Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Regenxbio Inc

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. F Hoffmann-La Roche Ltd

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Regeneron Pharmaceuticals Inc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Macular Degeneration Treatment Market

    29. Macular Degeneration Treatment Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Novartis AG Financial Performance
  • Table 48: Bausch Health Companies Inc Financial Performance
  • Table 49: Regenxbio Inc Financial Performance
  • Table 50: F Hoffmann-La Roche Ltd Financial Performance
  • Table 51: Regeneron Pharmaceuticals Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Novartis AG Financial Performance
  • Figure 48: Bausch Health Companies Inc Financial Performance
  • Figure 49: Regenxbio Inc Financial Performance
  • Figure 50: F Hoffmann-La Roche Ltd Financial Performance
  • Figure 51: Regeneron Pharmaceuticals Inc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report